TargetMol

A 83586C

Product Code:
 
TAR-T26456
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26456-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26456-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
A-83586C is a depsipeptide antibiotic from Streptomyces karnatakensis with potent against Gram-positive activity in vitro. A-83586C acts as a highly potent inhibitor of beta-catenin/TCF4 signaling within cancer cells, while simultaneously downregulating osteopontin (Opn) expression. A-83586C also inhibits E2F-mediated transcription by downregulating E2F1 expression and inducing dephosphorylation of the oncogenic hyperphosphorylated retinoblastoma protein (pRb).
CAS:
116364-81-9
Molecular Weight:
977.15
Purity:
0.98
SMILES:
[C@@](C(N[C@H]1[C@H](C(C)C)OC(=O)[C@@]([C@H](C)O)(NC(=O)[C@]2(N(C(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(O)C(=O)[C@@]3(N(C1=O)NCCC3)[H])NCCC2)[H])[H])=O)(CC)(O)[C@]4(O)O[C@H](\C(=C\[C@@H](C(/C(=C/C)/C)=O)C)\C)[C@@H](C)CC4

Documents

References

Hale KJ, Manaviazar S, George JH, Walters MA, Dalby SM. Total synthesis of (+)-azinothricin and (+)-kettapeptin. Org Lett. 2009 Feb 5;11(3):733-6. doi: 10.1021/ol802817t. PubMed PMID: 19175351. Smitka TA, Deeter JB, Hunt AH, Mertz FP, Ellis RM, Boeck LD, Yao RC. A83586C, a new depsipeptide antibiotic. J Antibiot (Tokyo). 1988 Jun;41(6):726-33. PubMed PMID: 3403366. Assem ES, Peh KH, Wan BY, Manaviazar S, Walters MA, George JH, Hale KJ. Pharmacological actions of a new synthetic cyclodepsipeptide, the A83586C-citropeptin hybrid, on complement C5a and G-Proteins. Inflamm Res. 2008;57 Suppl 1:S21-2. doi: 10.1007/s00011-007-0610-6. PubMed PMID: 18345507. Hale KJ, Manaviazar S, George J. Total synthesis of (+)-A83586C, (+)-kettapeptin and (+)-azinothricin: powerful new inhibitors of beta-catenin/TCF4- and E2F-mediated gene transcription. Chem Commun (Camb). 2010 Jun 21;46(23):4021-42. doi: 10.1039/c000603c. Epub 2010 Apr 19. PubMed PMID: 20405066.